Editing
Adrenal: Malignant Tumours
Jump to navigation
Jump to search
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
== Adrenal cortical carcinoma (ACC) == === Pathogenesis === * '''Classification: genetic vs. sporadic''' * '''Sporadic''' ** '''Cause of sporadic ACC remains unknown''' * '''Genetic''' ** '''Syndromes associated with ACC (6):''' **# '''Li-Fraumeni syndrome''' **# '''Beckwith-Wiedemann syndrome''' **# '''Lynch syndrome''' **# '''Carney complex''' **# '''MEN-1''' **# '''McCune-Albright syndrome''' === Diagnosis and Evaluation === ==== History and Physical Exam ==== * '''History''' ** '''Symptoms can be secondary to local or systemic disease burden and/or hypersecretion of adrenal hormones'''. *** ACCs associated with hypersecretion of adrenal hormones are characterized as being functional. **** '''Most ACCs will be functional at the time of presentation and the most common hormone secreted is cortisol''' ==== Laboratory ==== * '''Evaluating the functional status of adrenal tumors suspicious for ACC is essential''', not only for making the diagnosis of ACC but also for consideration of postoperative cortisol replacement and the potential use of tumor-secreted hormones as markers during postoperative surveillance. * '''When considering the functional status of a tumor that raises suspicion for ACC, glucocorticoid, mineralocorticoid, catecholamine, sexual steroid, and steroid precursor excesses should be evaluated''' ==== Imaging ==== * '''In incidentally detected adrenal tumors, size is a relative indicator of malignancy''' ** '''Risk of malignancy based on tumour size:''' *** '''< 4 cm: 5%''' *** '''> 4 cm: 10%''' *** '''> 6 cm: 25%''' *** Given the relationship between size and malignancy, '''it is currently recommended that adrenal tumors > 4-6 cm be surgically excised''' ** ACCs tend to be larger than benign adrenal tumors, with an average size of 10-12 cm on presentation * '''Radiographic characteristics of ACCs on CT imaging (5):''' *# '''Irregular borders''' *# '''Heterogenous enhancement''' *# '''Increased enhancement (mean 39 HU) compared to adenoma (8 HU)''' *# '''Calcifications''' *# '''Necrotic areas with cystic degeneration''' * '''MRI'''§ ** '''Normal adrenal gland''' *** '''TI: uniform intermediate signal intensity that is slightly less intense than that of the liver and renal cortical tissue''' *** '''T2: difficult to distinguish from retroperitoneal adipose tissue because of the presence of intracellular lipid with the gland''' ** '''Myelolipoma''' *** '''T1: bright''' *** '''T2: intermediate''' ** '''ACCs''' *** '''T1: isointense relative to the liver or spleen''' *** '''T2: intermediate to increased intensity''' *** '''Marked contrast uptake on gadolinium-enhanced images''' ** '''Pheochromocytoma''' *** '''Classically, bright signal intensity on T2-weighted imaging''' (best seen on fat suppression sequences)—termed the “light bulb” sign—was believed to be diagnostic. It is now clear that '''this imaging characteristic is neither specific nor sensitive enough to secure a diagnosis and must be interpreted with caution''' ==== Other ==== * '''Percutaneous needle biopsy is usually not performed before surgical excision owing to a clinically unacceptable risk of needle-tract seeding'''. ** In cases of surgically resectable disease, the information obtained from biochemical and radiographic evaluation should be enough to justify extirpation. === Pathology === * '''Modified Weiss criteria (5):§''' '''Necrotic''' '''ACC''' '''Metastasizes''' *# '''Necrosis''' *# '''Abnormal mitoses''' *# '''Cytoplasm (clear cells comprising ≤25% of the tumor)''' *# '''Capsular invasion''' *# '''Mitotic rate > 5 per 50 high power fields''' ** Calculate: 2x mitotic rate criterion + 2x clear cytoplasm criterion + abnormal mitoses + necrosis + capsular invasion (score of 3 or more suggests malignancy) * Traditional Weiss criteria: ** Abnormal mitoses ** Mitotic rate >5/hpf ** Diffuse Architecture of tumor cells ** Clear cells ≤25% ** Capsular/sinusoidal/venous invasion ** Furman grade (3 to 4) ** Necrosis === Management === * '''Multimodal treatment, surgical resection, radiation therapy, and systemic chemotherapy are often necessary''' * '''Systemic chemotherapy''' **'''Mitotane''' ***Oral synthetic derivative of the insecticide dichlorodiphenyltrichloroethane (DDT) ***Mechanism of action: '''inhibits several enzymes of the adrenal cortex including the cholesterol side-chain cleavage enzyme''' (P450scc, CYP11A1), '''11β-hydroxylase''' (CYP11B1), '''18-hydroxylase''' (aldosterone synthase, CYP11B2), and 3β-hydroxysteroid dehydrogenase (3β-HSD) to a lesser extent ***'''Most commonly used chemotherapeutic agent in the treatment of adrenal cortical carcinoma''' === Prognosis === * Despite aggressive surgical resection, adrenal carcinoma is associated with a high rate (60-80%) of recurrent disease * Factors associated with recurrence-free survival ** Tumor size ** Nodal status ** T stage ** Functional activity ** Capsular invasion * Local and systemic adjuvant therapy is often administered despite any clear evidence demonstrating improved survival * '''Factors associated with overall survival''' ** '''Margins status (most important)''' ** Tumor size ** Nodal status == Metastases == * Metastatic disease to the adrenals is common * '''In patients with a history of a previous malignancy, >50% of newly discovered adrenal lesions are metastatic; nevertheless, metabolic workup in these patients is recommended.''' * Bilateral and bulky disease (>4 cm) is necessary to produce biochemical evidence of adrenal insufficiency * '''Current imaging modalities supplemented by adrenal biopsy, when necessary, can frequently differentiate metastases from a primary adrenal tumor.''' == Questions == # List syndromes associated with increased risk of adrenal cortical carcinoma # What percentage of adrenal tumours >4cm are malignant? >6cm? # List radiographic characteristics of ACC on CT imaging # What is the most common hormone secreted by ACC? == Answers == # List syndromes associated with increased risk of adrenal cortical carcinoma # What percentage of adrenal tumours >4cm are malignant? >6cm? # List radiographic characteristics of ACC on CT imaging # What is the most common hormone secreted by ACC? #* Cortisol == References == * Wein AJ, Kavoussi LR, Partin AW, Peters CA (eds): CAMPBELL-WALSH UROLOGY, ed 11. Philadelphia, Elsevier, 2015, chap 65
Summary:
Please note that all contributions to UrologySchool.com may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
UrologySchool.com:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)
Navigation menu
Personal tools
Not logged in
Talk
Contributions
Create account
Log in
Namespaces
Page
Discussion
English
Views
Read
Edit
Edit source
View history
More
Search
Navigation
Main page
Clinical Tools
Guidelines
Chapters
Landmark Studies
Videos
Contribute
For Patients & Families
MediaWiki
Recent changes
Random page
Help about MediaWiki
Tools
What links here
Related changes
Special pages
Page information